Document is current

Any future updates will be listed below

Molecular Docking Study and Toxicity Risk Assessment of Some Novel Benzimidazole Oxime Ether Derivatives as CYP51 Inhibitors

Crossref DOI link: https://doi.org/10.29252/sjimu.26.6.99

Published Online: 2019-03-01

Update policy: https://doi.org/10.29252/crossmark-policy

About CrossMark